RNA therapeutics companies develop medicines that use RNA molecules to alter protein production, silence disease-associated genes or deliver therapeutic instructions to cells. These approaches support the treatment of genetic disorders, cancer, infectious disease and other conditions.
This category includes companies working on:
Browse 62 UK RNA therapeutics companies below.
Early phase clinical trial CRO based at London Bridge
Richmond Pharmacology is a contract research organisation specialising in early phase and first-in-human clinical trials for pharmaceutical and biotech companies. Operating from hospital-adjacent facilities at London Bridge and St George's University London, the company has conducted over 20% of all UK Phase I studies…
Reagents that stabilise and fix RNA, DNA and tissue samples
RNAssist is a reagents company developing patented stabilisation and fixation products for biological samples. Its formulations, based on deep eutectic solvents, preserve RNA, DNA, proteins and cell structure at the point of collection and are compatible with downstream methods such as single-cell sequencing and…